1-2 of 2
Faith Brianne Buchanan, PA
Close
Sort by
Journal Articles

Safety and Antitumor Effects of CD19-Specific Autologous Chimeric Antigen Receptor-Modified T (CAR-T) Cells Expressing the Inducible Caspase 9 Safety Switch (iC9-CAR19 T Cells) in Adult Acute Lymphoblastic Leukemia (ALL)

Matthew C Foster, MD, Philip A. Roehrs, MD, George E Hucks, MD, Natalie S Grover, MD, Paul M. Armistead, MD PhD, Katarzyna Jamieson, MD, Faith Brianne Buchanan, PA, J. Kaitlin C Morrison, PhD, Spencer Laing, BA, Catherine Joyce Arago Cheng, BS, Jonathan S. Serody, MD, Gianpietro Dotti, MD, Barbara Savoldo, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-139051
Published: 2020
Journal Articles

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin

Natalie S Grover, MD, Steven I Park, MD, Anastasia Ivanova, PhD, Paul Eldridge, PhD, Kathryn McKay, MS, MT (ASCP), Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Deborah Covington, RN, BSN, John West, PhD, S. Elizabeth Sharf, RN, BSN, J. Kaitlin Morrison, PhD, Shaw Scott, Erin Crecelius, MA, Desirae Shelley, Maurice Alexander, PharmD, Faith Brianne Buchanan, PA, Emily Herrick Kassam, NP, Megan McElfresh, PA-C, Alicia R Pinto, NP, Angela Denise Spruill, ANP, Ashley Zanter, ANP, Kimberly Wehner, FNP, Christopher Dittus, DO, Thomas C. Shea, MD, Gianpietro Dotti, MD, Jonathan S Serody, MD, Anne Beaven, MD, Barbara Savoldo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 681.
https://doi.org/10.1182/blood-2018-99-113534
Published: 2018